OMND — Optimind Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.58m
- CA$1.12m
- CA$0.17m
Annual cashflow statement for Optimind Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | Final |
| Net Income/Starting Line | -0.214 | -0.025 | 0.131 | -0.172 | -3.08 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.003 | -0.012 | -0.207 | 0.094 | 2.13 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.058 | -0.015 | -0.022 | -0.003 | -0.128 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.159 | -0.052 | -0.098 | -0.081 | -1.04 |
| Other Investing Cash Flow Items | — | — | — | — | -0.221 |
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | — | — | -0.221 |
| Financing Cash Flow Items | — | — | -0.004 | 0 | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.21 | 0.008 | 0.094 | 0.076 | -0.045 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.051 | -0.045 | -0.003 | -0.006 | -1.31 |